Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC. - Wikidata - wikimedia - TriplyDB

Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC.

Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC.

http://www.wikidata.org/entity/Q39741286

about

hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges Tapping Stem Cells to Target AMD: Challenges and Prospects Recent developments in β-cell differentiation of pluripotent stem cells induced by small and large molecules Adipose tissue stem cells: the great WAT hope A poor imitation of a natural process: a call to reconsider the iPSC engineering technique Urine-derived induced pluripotent stem cells as a modeling tool to study rare human diseases Utilizing induced pluripotent stem cells (iPSCs) to understand the actions of estrogens in human neurons Progress and bottleneck in induced pluripotency Induced pluripotency: history, mechanisms, and applications.Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.Pluripotent stem cells: the last 10 years.Induced pluripotency of human prostatic epithelial cells.Myc transcription factors: key regulators behind establishment and maintenance of pluripotency.Mannitol-containing macroporous calcium phosphate cement encapsulating human umbilical cord stem cells Rapid and efficient generation of functional motor neurons from human pluripotent stem cells using gene delivered transcription factor codes.Gas-foaming calcium phosphate cement scaffold encapsulating human umbilical cord stem cells.Does the Harvesting Technique Affect the Properties of Adipose-Derived Stem Cells?-The Comparative Biological Characterization.Non-rigid calcium phosphate cement containing hydrogel microbeads and absorbable fibres seeded with umbilical cord stem cells for bone engineering Induced pluripotent stem cells: origins, applications, and future perspectives.Applications of patient-specific induced pluripotent stem cells; focused on disease modeling, drug screening and therapeutic potentials for liver disease.Advancements in reprogramming strategies for the generation of induced pluripotent stem cells.Derivation of human induced pluripotent stem cells for cardiovascular disease modeling.From skin to the treatment of diseases--the possibilities of iPS cell research in dermatology.Induced pluripotent stem cells and personalized medicine: current progress and future perspectives.Advances and applications of induced pluripotent stem cells.An experimental approach to the generation of human embryonic stem cells equivalents.In vitro neurogenesis: development and functional implications of iPSC technology.Osteogenically differentiated mesenchymal stem cells and ceramics for bone tissue engineering.Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine Current status of treating neurodegenerative disease with induced pluripotent stem cells.Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors.High plasticity of pediatric adipose tissue-derived stem cells: too much for selective skeletogenic differentiation?Patient-specific pluripotent stem cells in neurological diseases.Reprogramming adipose tissue-derived mesenchymal stem cells into pluripotent stem cells by a mutant adeno-associated viral vector Enhancers and super-enhancers have an equivalent regulatory role in embryonic stem cells through regulation of single or multiple genes.The fast release of stem cells from alginate-fibrin microbeads in injectable scaffolds for bone tissue engineering.Time-course transcriptome analysis of human cellular reprogramming from multiple cell types reveals the drastic change occurs between the mid phase and the late phase.Diversity among POU transcription factors in chromatin recognition and cell fate reprogramming.DPPA5 Supports Pluripotency and Reprogramming by Regulating NANOG Turnover.

P2860

Q26751506-6BB2BAC5-EDCE-43BA-B981-F7078E4DC41B Q26775061-8D44DB38-5B88-49F8-B056-9DADAB930F9F Q26799625-C8BE1B5C-227E-45D4-8E01-557AD81874BD Q26825664-D6E89701-F278-422D-B34D-850D3615BAF0 Q26849284-10366228-AB3B-4867-B2FD-6967126164C3 Q26851933-40B61D53-50C7-41B5-95A0-CA0173333B8C Q28073204-5F05FA66-2EA9-4D41-8248-B2710789CB0B Q28081565-FF581042-1964-4219-8045-D52306407167 Q28652287-267D2B34-8A13-4E5B-9DBD-C982735F1FCC Q34206028-D795F37D-5799-416E-AE92-8CC0F8A69E4E Q34231818-0B283172-5EED-4A86-A76B-3873EFE68965 Q34546417-40D9DD78-D593-4927-AFD3-000B63B55EDE Q34745924-88169E3A-2651-4273-8B77-1486A8956D67 Q35054858-75E3C19C-8B90-4254-A0D8-2ACF50B1D2A7 Q35129778-C84AC215-DF20-4FF9-A6B7-7489320ABA90 Q35285752-CD465E04-860B-482B-9BFF-B10CC300F44D Q35855707-B8975DD5-08C0-487E-B7DA-A337DC66148A Q36127041-8382CCB0-3D3B-4B9D-96AA-EECA5C735595 Q36809126-41B7AF24-6B5D-4D8D-9506-CD44990BCD54 Q37392636-18448C9D-13CA-44C1-9D8F-9436298F39D9 Q37823231-B4A2FE08-B34A-4205-8D97-95E96D244A3E Q37850732-E11D4E45-AC9C-4294-B8E4-0D8957002D10 Q37870042-20833E2D-3710-4AF4-BECB-120F471C4A40 Q37876469-D8847017-A80F-4CE5-9989-FE4CBEB8FE7D Q37976707-68354A65-DB92-4789-99E6-8F52B6B911DA Q37988004-F5F33107-58F7-4F0B-871A-49B023798B15 Q38154562-B148A31F-62CB-40BA-84BD-9EC7CCC59E3E Q38164195-B704D8F0-8DF5-4ABF-BBF3-AD090B1FCCEA Q38168864-7F67429C-5358-4E27-978B-C309D556A4A4 Q38358569-3221955D-302B-4E3A-9D18-EB628DDEA44B Q38691178-84962D09-BD71-4A10-9E00-03CE7AD153D9 Q40813551-C445744E-B637-4A2C-B0DB-133341707A65 Q40882482-0C9040FA-3226-4362-A587-DFBEB76F6552 Q41836711-8B4E77F9-94C5-4D98-A09B-81CE0CCC2431 Q41896060-4D690448-877E-42AE-B874-71CCB8A23FB1 Q42324921-05846EB1-9FC4-4453-8E16-EF80F3AB5813 Q42872488-A9A58D9F-64B4-4A3F-826C-2475A1CD5CC4 Q47157700-959213D2-06F9-4BC2-96EC-36821347C792 Q48239230-6CEB88AE-FC95-4115-B1AF-74BD60666B93 Q50544749-5A2BE759-8D19-4909-B38A-61DDA216997E

P2860

Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC.

http://www.wikidata.org/entity/Q39741286

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Generation of induced pluripot ...... ived stem cells without c-MYC.

@en

Generation of induced pluripot ...... ived stem cells without c-MYC.

@nl

type

label

Generation of induced pluripot ...... ived stem cells without c-MYC.

@en

Generation of induced pluripot ...... ived stem cells without c-MYC.

@nl

prefLabel

Generation of induced pluripot ...... ived stem cells without c-MYC.

@en

Generation of induced pluripot ...... ived stem cells without c-MYC.

@nl

P1433

Q39741286-9A225343-6578-45BD-88D8-0C39FB9A2E83

P1476

Q39741286-85D81AAF-4171-477F-A327-93482954E1A1

P2093

Q39741286-1C9ECF54-F49D-4728-B55D-C31A23867B3C

Q39741286-7BD2E72C-DF4B-4658-898A-A1C66941C100

Q39741286-874BD37D-2AA8-4D40-915B-01E13394DE4C

Q39741286-89D74AA0-2964-4D76-A58A-AA5865C39FDA

Q39741286-91EBC328-A0B7-4BFF-A999-5467E1562B5A

Q39741286-A9F63440-90D9-4892-A59C-92AB1DAC5679

Q39741286-CECFB06B-AF39-42F7-916C-9A4F3A6319AF

Q39741286-E62777F2-1571-4106-A7EB-1BC90580B8EF

P304

Q39741286-104D5452-9B35-4F50-8C5B-C9B4D683F59F

P31

Q39741286-AB582810-6720-4AA7-9744-B7C3FA869C7B

P356

Q39741286-9CBD4BCE-9C22-4F59-B8E0-B1087C0BB335

P433

Q39741286-C9D1C7C7-7B0E-4012-89BB-A8E01323F162

P478

Q39741286-98C852DE-042D-43B1-B502-DAF0C368DB93

P577

Q39741286-3466F169-E7CC-4E1B-BDF9-3517545BFAAD

P698

Q39741286-C2189DF5-F60A-4AEE-A2C4-89011681954E

P921

Q39741286-FD02023B-73C6-44F5-8B1E-5C9185BF056E

P356

TEN.TEA.2009.0747

P1433

Tissue Engineering. Part A

P1476

Generation of induced pluripot ...... ived stem cells without c-MYC.

@en

P2093

Hajime Ohgushi

http://www.w3.org/2001/XMLSchema#string

Hiroe Ohnishi

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Kato

http://www.w3.org/2001/XMLSchema#string

Koji Hattori

http://www.w3.org/2001/XMLSchema#string

Mari Sasao

http://www.w3.org/2001/XMLSchema#string

Mika Tadokoro

http://www.w3.org/2001/XMLSchema#string

Tetsuhiro Aoki

http://www.w3.org/2001/XMLSchema#string

Yasuaki Oda

http://www.w3.org/2001/XMLSchema#string

P304

2197-2206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/TEN.TEA.2009.0747

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20146561

http://www.w3.org/2001/XMLSchema#string

P921

Human Induced Pluripotent Stem Cells